Prediction of neoadjuvant therapy response to HER2-positive and triple-negative breast cancer: a multicenter proof-of-concept study
Computer Methods and Programs in Biomedicine · 2026
DOI: 10.1016/j.cmpb.2025.109130 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Computer Methods and Programs in Biomedicine, 2026. Verfasst von Min Fu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Imaging, The Affiliated Hospital of Qingdao University, Qingdao, China; Department of Radiology, The Affiliated Hospital of Qing…. Hauptthemen laut MEDLINE: Neoadjuvant Therapy, Triple Negative Breast Neoplasms, Erb-b2 Receptor Tyrosine Kinases, Breast Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Breast Imaging, The Affiliated Hospital of Qingdao University, Qingdao, China; Department of Radiology, The Affiliated Hospital of Qingdao University, Qingdao, China.
- Department of Radiology, The Affiliated Hospital of Qingdao University, Qingdao, China.
- Department of Thyroid Surgery, The Affiliated Hospital of Qingdao University, Qingdao, China.
- Department of Breast Imaging, The Affiliated Hospital of Qingdao University, Qingdao, China; Department of Radiology, The Affiliated Hospital of Qingdao University, Qingdao, China. Electronic address: chenjingjingsky@qd…
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Fu, M., Zhao, H., Pang, J., Hua, H., Lin, X., Liu, J., He, Y., Ming, X., Meng, X., & Chen, J. (2026). Prediction of neoadjuvant therapy response to HER2-positive and triple-negative breast cancer: a multicenter proof-of-concept study. Computer Methods and Programs in Biomedicine. https://doi.org/10.1016/j.cmpb.2025.109130
Vancouver
Fu M, Zhao H, Pang J, Hua H, Lin X, Liu J, et al. Prediction of neoadjuvant therapy response to HER2-positive and triple-negative breast cancer: a multicenter proof-of-concept study. Computer Methods and Programs in Biomedicine. 2026. doi:10.1016/j.cmpb.2025.109130
BibTeX
@article{Fu2026,
author = {Fu, Min and Zhao, Haichen and Pang, Jing and Hua, Hui and Lin, Xin and Liu, Jingjing and He, Yinxin and Ming, Xiaoni and Meng, Xinran and Chen, Jingjing},
title = {Prediction of neoadjuvant therapy response to HER2-positive and triple-negative breast cancer: a multicenter proof-of-concept study},
journal = {Computer Methods and Programs in Biomedicine},
year = {2026},
doi = {10.1016/j.cmpb.2025.109130}
}
EUVIMED